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Posttranslational modifications of core histones contribute to driving changes in chromatin
conformation and compaction. Herein, we investigated the role of histone deacetylation on the
mitotic process by inhibiting histone deacetylases shortly before mitosis in human primary
fibroblasts. Cells entering mitosis with hyperacetylated histones displayed altered chromatin
conformation associated with decreased reactivity to the anti-Ser 10 phospho H3 antibody,
increased recruitment of protein phosphatase 1- on mitotic chromosomes, and depletion of
heterochromatin protein 1 from the centromeric heterochromatin. Inhibition of histone deacety-
lation before mitosis produced defective chromosome condensation and impaired mitotic pro-
gression in living cells, suggesting that improper chromosome condensation may induce mitotic
checkpoint activation. In situ hybridization analysis on anaphase cells demonstrated the presence
of chromatin bridges, which were caused by persisting cohesion along sister chromatid arms after
centromere separation. Thus, the presence of hyperacetylated chromatin during mitosis impairs
proper chromosome condensation during the pre-anaphase stages, resulting in poor sister chro-
matid resolution. Lagging chromosomes consisting of single or paired sisters were also induced
by the presence of hyperacetylated histones, indicating that the less constrained centromeric
organization associated with heterochromatin protein 1 depletion may promote the attachment of
kinetochores to microtubules coming from both poles.
INTRODUCTION
The successful segregation of chromosomes at mitosis relies
on the coordinated execution of cytoskeletal and chromo-
somal events. The interphase microtubules reorganize to
form a bipolar mitotic spindle and the relaxed interphase
chromatin orderly compacts into highly condensed rod-like
structures. Posttranslational modifications of nucleosome
core histones contribute substantially to driving changes in
chromatin conformation and compaction. Acetylation on
lysine residues on the amino-terminal tails of histones con-
tributes to the formation of a transcriptionally competent
environment, by decreasing the affinity of the acetylated N
termini for DNA and allowing access of general transcrip-
tion factors to DNA. Conversely, deacetylated histones are
mainly associated with compact chromatin states and tran-
scriptional repression (for reviews, see Grunstein, 1997;
Wade et al., 1997; Cheung et al., 2000). Underacetylated H3
and H4 histones abound in constitutive heterochromatin
regions of human metaphase chromosomes and in the het-
erochromatic inactive X chromosome (Jeppesen et al., 1992;
Belyaev et al., 1996). An overall reduction in acetylated H3
and H4 histones has also been observed in mitotic cells
compared with interphase nuclei (Kruhlak et al., 2001).
Another histone posttranslational modification relevant to
chromatin dynamics during mitosis is Ser 10 phosphoryla-
tion of histone H3. The presence of this modified histone has
been correlated with mitotic chromosome condensation in
several eukaryotic systems (Hendzel et al., 1997; Wei et al.,
1998). H3 phosphorylation at Ser10 is governed by the ac-
tivity of aurora/Ipl1 kinases (Speliotes et al., 2000; Adams et
al., 2001; Giet and Glover 2001; Crosio et al., 2002) in com-
petition with the phosphatase activity of the serine/threo-
nine protein phosphatase 1 (Hsu et al., 2000; Murnion et al.,
2001). It has been shown that Ser 10-modified histone colo-
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calizes with the human condensin complex during G2/
prophase (Schmiesing et al., 2000), suggesting that this mod-
ification may have a role in destabilizing local chromatin
structure to allow access of condensation factors to DNA or
in recruiting the condensation machinery on the modified
histone amino-terminal tail (Wei et al., 1998; Schmiesing et
al., 2000).
Although the importance of mitotic spindle alterations
such as multipolarity or defective kinetochore–microtubule
interactions in causing unbalanced chromosome segregation
and aneuploidy is widely acknowledged, the role of defects
in chromatin dynamics during mitosis in promoting this
kind of genomic instability is still largely unexplored. Re-
cently, a study with mutant Tetrahymena strains harboring
unphosphorylatable H3 histone demonstrated that Ser-10
phosphorylation is essential for proper chromosome con-
densation and segregation (Wei et al., 1999). Moreover, in
fission yeast a prolonged exposure to trichostatin A (TSA), a
specific histone deacetylase inhibitor (Yoshida et al., 1995)
was shown to lead to H3 and H4 hyperacetylation in cen-
tromeric heterochromatin, derepression of reporter genes in
centromeric regions, and chromosome loss (Ekwall et al.,
1997). Finally, treatment of mouse cells with TSA for several
days induced a relocation of pericentromeric heterochro-
matic blocks to the nuclear periphery, defective association
of heterochromatin protein 1 (HP1) to pericentromeric re-
gions, centromere-positive micronuclei, and abnormal an-
aphases (Taddei et al., 2001).
In our work, we have investigated the mechanisms pro-
moting abnormal chromosome segregation when histones
are maintained hyperacetylated during mitosis and the role
of histone H3 phosphorylation in hyperacetylation-induced
defective segregation in mammalian cells. To this aim, we
inhibited histone deacetylation with TSA shortly before mi-
tosis, rather than with long-term treatments, to avoid the
known profound effects of histone deacetylase inhibition on
gene expression and cell growth. Indeed, long-term treat-
ments with histone deacetylase inhibitors have been shown
to modulate gene expression (Van Lint et al., 1996), to influ-
ence acetylation of histones on promoters of target genes
(Richon et al., 2000), and to promote growth arrest, differen-
tiation, and apoptosis in different tumor cells (Kosugi et al.,
1999; Saunders et al., 1999). To selectively investigate the role
of histone modifications before mitosis on the fidelity of the
mitotic process, the exposure regimen was built to influence
histone deacetylation either during synthesis of late-repli-
cating heterochromatic regions or during prophase mitotic
condensation in exponentially growing human primary fi-
broblasts.
MATERIALS AND METHODS
Cell Cultures and Drug Treatments
Human lung diploid fibroblasts (MRC-5 cells), PtK1 cells, and HeLa
cells were obtained from the American Type Culture Collection
(Rockville, MD) and maintained in minimal essential medium sup-
plemented with fetal calf serum (MRC-5 cells: 15%; PtK1 and HeLa
cells: 10%), antibiotics, and nonessential amino acids. Cells were
grown at 37°C, in a humidified atmosphere, with 5% CO2. For
experiments, MRC-5 and PtK1 cells were grown on sterilized cov-
erslips inside 35-mm Petri dishes. For TSA (Calbiochem, San Diego,
CA) treatment a 500-g/ml stock solution was prepared in di-
methyl sulfoxide (DMSO) (Sigma-Aldrich, St. Louis, MO). MRC-5
cultures were treated with 200, 500, or 1000 ng/ml TSA for 1 h or 7 h
or received the corresponding DMSO concentration as a control.
Coverslips were then fixed and either Giemsa-stained for mitotic
index evaluation, or processed for immunofluorescence or fluores-
cence in situ hybridization (FISH). For Giemsa staining, coverslips
were fixed in a 3:1 methanol/acetic acid mixture and air dried
before staining. The number of mitoses was recorded on 2000 cells/
experimental point. Immunoblotting, immunofluorescence, and in
vivo analysis of chromosome condensation were performed on cells
treated for 1 or 7 h with 500 ng/ml TSA or receiving 0.1% DMSO.
Antibodies and Immunofluorescence
Anti-Ser 10 phospho H3, and anti-Lys 9 acetyl H3 (a gift from Dr. C.
Nervi, University La Sapienza, Rome, Italy) rabbit antibodies were
from Upstate Biotechnology (Lake Placid, NY). MPM-2 mouse an-
tibody was from DAKO (Carpinteria, CA). Coverslips were washed
in phosphate-buffered saline (PBS), fixed in absolute cold methanol,
and then permeabilized in PBS  0.5% Triton-X. After rinsing in
PBS with 0.1% Tween 20, cells were blocked overnight in PBS/
bovine serum albumin. Coverslips were incubated 2 h with the
appropriate antibodies, rinsed in PBS with 0.1% Tween 20, and
incubated for 45 min with the appropriate secondary antibodies
(fluorescein isothiocyanate anti-rabbit and Texas Red anti-mouse
antibodies from Vector Laboratories, Burlingame, CA). Cells were
counterstained with 4,6-diamidino-2-phenylindole (DAPI) and cov-
erslips mounted in antifade solution (Vector Laboratories). Rabbit
antibody against PP1- protein was kindly provided by Dr. E.
Villa-Moruzzi (University of Pisa, Pisa, Italy), and PP1- immuno-
staining was performed according to Andreassen et al. (1998). For
HP1 localization on mitotic chromosomes, MRC-5 or PtK1 cultures
were fixed after 7- or 1-h treatment with TSA combined with a 2-h
incubation in 0.5 M colchicine before fixation to obtain mitotic
spreads. Cells were then swollen in a hypotonic solution (37.5 mM
KCl containing protease inhibitors and phenylmethylsulfonyl fluo-
ride [PMSF]) and fixed in 4% (wt/vol) paraformaldehyde in PHEM
buffer. Cells were then permeabilized with 0.5% Triton X-100 in
PHEM buffer for 10 min and blocked for 1 h with 5% goat serum.
They were then incubated overnight with CREST anti-kinetochore
serum (Antibodies Incorporated, Davies, CA) and 2HP 1H5 anti-
HP1 mouse antibody (a generous gift of Prof. P. Chambon, Centre
National de la Recherche Scientifique, Strasbourg, France). Anti-
body detection and counterstaining were performed as described
above except that anti-human and anti-mouse secondary antibodies
(Vector Laboratories) were used.
FISH Analysis
MRC-5 cells treated for 1 or 7 h with 500 ng/ml TSA were fixed in
a 3:1 methanol/acetic acid mixture. FISH staining was performed
using 7 ng of biotin-labeled chromosome 16 alphoid probe (Oncor,
Gaithersburg, MD) and 6 ng of digoxigenin-labeled chromosome 1
classical satellite DNA (pUC 1.77 probe; Cooke and Hindley, 1979)
for each coverslip. FISH staining was performed as described pre-
viously (Cimini et al., 1999).
Microscopy
All preparations were examined under an Olympus Vanox micro-
scope equipped with a 100 (1.35 numerical aperture) oil immer-
sion objective and a SPOT charge-couple device camera (Diagnostic
Instruments, Sterling Heights, MI). Color encoded images were
acquired using ISO 2000 software (DeltaSistemi, Rome, Italy) and
processed with Adobe Photoshop software. For measuring HP1
fluorescence at centromeres, all digital images were obtained with
the same camera settings. The best in-focus image of a kinetochore
was determined visually and, based on the CREST signal, a region
corresponding to the kinetochore was generated using Photoshop
software. The mean fluorescence intensity in the region was then
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recorded together with the mean fluorescence intensity of a close
area outside the kinetochore (background fluorescence) and the
fluorescence intensity of the background was subtracted from the
kinetochore fluorescence. The average value of HP1 fluorescence
was calculated for at least 51 kinetochores per each experimental
condition, and results were compared using a statistical t test.
Analysis of Mitotic Progression and Chromosome
Dynamics in Live Cells
A plasmid carrying the full-length coding sequence for H2B histone
subcloned into the pEGFP-N1 mammalian expression vector (a
generous gift from Dr. P. Magalhaes, University of Padua, Padua,
Italy) was used to obtain a PtK1 cell population enriched in H2B-
green fluorescent protein (GFP)–expressing cells as described in
Cimini et al. (2002). H2B-GFP–expressing PtK1 cultures were incu-
bated in 500 ng/ml TSA for 30 min or 5 h and then observed by
fluorescence and phase contrast microscopy under a Nikon Eclipse
300 inverted microscope equipped with a 37°C heated stage, 60
(0.7 numerical aperture) objective. Prophase cells were localized and
mitotic progression was observed. Time intervals from nuclear en-
velope breakdown to alignment of all chromosomes to the meta-
phase plate (prometaphase), from chromosome alignment to an-
aphase onset (metaphase), from anaphase onset to cleavage furrow
appearance (anaphase), and from cleavage furrow appearance to
completion of cytokinesis (telophase/cytokinesis) were recorded.
Immunoblotting
Cell pellets were resuspended in 20 mM HEPES, 10 mM KCl, 1.5
mM MgCl2, 1 mM EDTA, 1 mM Na3VO4, 20 mM NaF, 1 mM PMSF,
1 mM dithiothreitol, 10 g/ml aprotinin, 10 g/ml leupeptin, and
0.5% NP-40. Cells were passed through a 26-gauge needle 10 times
and then briefly centrifuged at 13,000 rpm. Nuclear pellets were
resuspended in high salt buffer (50 mM HEPES, 500 mM NaCl, 1
mM PMSF, 1 mM Na3VO4, 20 mM NaF, 10 g/ml aprotinin, 1%
NP-40) and sonicated on ice for 10 s at 14-m amplitude in a
Soniprep 150 apparatus equipped with a microtip. Thereafter, pel-
lets were extracted for 30 min on ice in the high salt solution and
supernatant from a 13,000 rpm centrifugation was kept at 80°C.
Protein content was measured using the Bradford reagent (Sigma-
Aldrich). Equal amounts of nuclear proteins from TSA-treated and
untreated cells were electrophoresed through SDS-PAGE and then
electrotransferred onto nitrocellulose membranes in a Trans-Blot
apparatus. Membranes were blocked in Tris-buffered saline contain-
ing 0.1% Tween 20 and 5% low fat dry milk for 1 h and then
incubated with anti-acetylated H3 or anti-phospho H3 antibody.
After multiple washes in Tris-buffered saline containing 0.1%
Tween 20 and incubation with anti-rabbit horseradish peroxidase-
linked antibody, immunocomplexes were revealed by a chemilumi-
nescence kit (Amersham Biosciences, Piscataway, NJ).
RESULTS
Cells Entering Mitosis with Hyperaceylated
Histones Display Distorted Chromatin
Conformation
To investigate the role of histone deacetylase inhibition be-
fore mitosis on the accuracy of cell division, we first studied
whether entry into mitosis was affected by deacetylase inhi-
bition by analyzing the mitotic index in TSA-treated human
primary MRC-5 fibroblasts. The frequency of mitotic cells
was reduced by 30% already at 200 ng/ml TSA (Figure 1A),
when cells were kept in the presence of the drug during
prophase or during synthesis of late-replicating heterochro-
matic regions (1 or 7 h before fixation, respectively), in
accordance with available data showing a G2 checkpoint
induction by deacetylase inhibitors in normal cells (Qiu et al.,
2000). For 1-h TSA treatment, a further 30% decrease of the
mitotic index was observed in cells treated with 500 ng/ml
TSA and no further reduction was observed at 1000 ng/ml,
indicating that inhibition of deacetylation and biological effects
were fully accomplished with 500 ng/ml TSA. Based on these
results, we decided to perform our subsequent studies on
chromosome dynamics during mitosis at the dose of 500
ng/ml TSA. Then, we directly tested whether histone deacety-
lase activity was efficiently inhibited in our experimental con-
ditions. We performed immunofluorescent detection of acety-
lated H3 histone in TSA-treated cells by using an anti-Lys 9
acetyl H3 antibody. The acetylated form of histone H3 was
undetectable on control interphase and mitotic MRC-5 cells
after immunostaining (Figure 1B, TSA), whereas an intense
staining was observed both on nuclei and mitotic cells in cul-
tures treated for 1 h with TSA (Figure 1B, TSA). In TSA-
treated cultures the strong antibody reactivity of mitotic cells
(arrow in Figure 1B, TSA) demonstrated that in the presence
of the deacetylase inhibitor cells entered mitosis with acety-
lated histones. Western blotting analysis on nuclear proteins
confirmed the immunofluorescence results, showing an im-
pressive accumulation of acetylated H3 histones in cells treated
for 1 h with TSA alone or in combination with nocodazole
(Figure 1C). Therefore, we could conclude that deacetylase
activity was efficiently inhibited after 1-h treatment with 500
ng/ml TSA.
We next investigated whether acetylation of Lys 9 on
histone H3 during prophase interfered with Ser 10 phos-
phorylation, the mitosis-specific modification of the H3 his-
tone. In human fibroblasts, the appearance of anti-phospho
H3 antibody reactivity was a very early marker of chromo-
some condensation because phospho H3 was already visible
on nuclei that did not display chromosome condensation as
detected by DAPI staining (Figure 2A, first row, arrow), and
H3 histone was heavily phosphorylated in metaphase (Fig-
ure 2A, second row, arrow) and anaphase (Figure 2A, sec-
ond row, arrowhead). In TSA-treated cells a decreased an-
tibody reactivity was observed both on metaphase and
anaphase chromosomes (Figure 2A, TSA, third and forth
row, respectively), suggesting a decreased phosphorylation
of the H3 histone when hyperacetylated. When metaphases
were observed at higher magnification, the phospho H3
antibody reactivity seemed confined to the periphery of the
chromosome axis in TSA-treated cells compared with the
intense staining all over chromatid arms in control cells
(Figure 2B). The decreased phospho H3 reactivity was ob-
served both in cells receiving TSA for 7 h (Figure 2A) and in
cells treated for 1 h before fixation (Figure 2B).
We then examined whether deacetylase inhibition in-
duced a nonspecific inhibition of mitotic kinase activities,
which could explain both the decreased reactivity to the
phospho H3 antibody and the reduced mitotic entry ob-
served in TSA-treated cells. We performed double immuno-
fluorescence staining with an anti-phospho H3 antibody and
the MPM-2 antibody, which is known to recognize phospho-
epitopes on several mitotic proteins (Ding et al., 1997). Mi-
totic chromosomes from control cultures were strongly pos-
itive for the phospho H3 antibody and the MPM-2
fluorescence was evenly distributed all over the mitotic cell
(Figure 3A, TSA). Remarkably, the presence of the MPM-2
reactive epitopes was clearly unaffected by the TSA treat-
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ment also in cells that completely lacked the phospho-his-
tone staining (Figure 3A, TSA). In 90% of control met-
aphases, reactivities to phospho H3 and MPM-2 antibodies
were associated, whereas in cell cultures receiving TSA for
7 h 40% of MPM-2 positive metaphases were weakly pos-
itive or completely dull for phospho H3 staining (Figure 3B).
A decreased phospho H3 staining in MPM-2–positive cells
was also observed when nocodazole-treated cells were in-
cubated with TSA (Figure 3B). These data excluded that
histone acetylation at prophase might promote a general
inhibition of mitotic kinases.
The reduced H3 phosphorylation, if not due to a general
inhibition of kinase activity, might depend on an increased
dephosphorylation. For this reason, we decided to analyze
the association of the  isoform of the PP1 phosphatase to
mitotic chromosomes. PP1- is a major mitotic chromatin-
associated protein and its phosphatase activity counteracts
the aurora B kinase activity on the H3 histone. We used an
antibody specific to PP1- and showed that during inter-
phase PP1- displays a homogeneous nuclear distribution
both in control and in TSA-treated cells (Figure 4A). How-
ever, a stronger signal for PP1- was evident on interphase
nuclei, when cells were treated with the deacetylase inhibi-
tor (Figure 4A, TSA). The observation of mitotic cells
showed that PP1- was specifically associated to condensed
chromosomes during mitosis and that chromosomes from
TSA-treated cultures displayed a much stronger staining
compared with untreated cultures (Figure 4B).
We finally tested directly the phosphorylation state of the
H3 histone by using Western blot analysis. Surprisingly,
when nuclear proteins were assayed by Western blot the
intracellular levels of Ser 10 phosphorylated H3 histone
were similar in samples obtained from asynchronously
growing control MRC-5 cells or cells exposed for 1 or 7 h to
the deacetylase inhibitor (Figure 5, MRC-5). Comparable
levels of phospho H3 histone were also observed in MRC-5
cells arrested in mitosis by a 7-h nocodazole treatment and
in cells receiving the deacetylase inhibitor together with
nocodazole (Figure 5, MRC-5). To investigate H3 phosphor-
ylation in a mitotic cell population, HeLa cells were synchro-
nized in S phase by a thymidine/aphidicolin block, and H3
phosphorylation was assayed 13 h after release, the time
when most cells entered mitosis, with or without a preced-
ing incubation with TSA. In this case, intracellular levels of
phospho H3 histone also did not show significant variations
(Figure 5, HeLa), corroborating the finding obtained in asyn-
chronous human fibroblasts.
Figure 1. Short-term treatments with the deacetylase inhibitor TSA decrease mitotic index and induce histone hyperacetylation in mitotic
cells. (A) Asynchronously growing human fibroblast MRC-5 cells were treated for 1 h (solid bars) or 7 h (squared bars) with different
concentrations of TSA and the mitotic frequency was evaluated on Giemsa-stained slides. The graph reports the mean  SE of the results
obtained in three independent experiments. (B) Immunofluorescence detection of Lys 9 acetylated H3 histone on interphase and mitotic
(arrows) MRC-5 cells fixed after 7 h in the presence of 1% DMSO (TSA) or 500 ng/ml TSA (TSA). Similar results were obtained after 1-h
incubation with 500 ng/ml TSA. Bar, 5 m. (C) Anti Lys 9 acetyl H3 immunoblotting of nuclear proteins from MRC-5 cells incubated for 1 h
with 0.1% DMSO (control) or 500 ng/ml TSA (TSA) or receiving 35 ng/ml nocodazole for 18 h (NOC) or 35 ng/ml nocodazole for 18 h and
500 ng/ml TSA for the last 2 h (NOC  TSA).
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Together, the above-mentioned results suggested that Lys
9 acetylation does not interfere with Ser 10 phosphorylation
but rather indicated that the presence of Lys 9 acetylated/
Ser 10 phosphorylated tails may modify DNA/histone in-
teraction. An altered DNA/histone association might de-
crease the accessibility of the N-tails to the antibody
recognizing Ser 10 phosphorylated H3 on mitotic prepara-
tions, thus reducing the phospho H3 staining of mitotic
chromosomes. Reduced chromatin accessibility might also
increase the loading on DNA of the chromatin-associated
kinases and phosphatases that regulate H3 phosphorylation.
This might explain the recruitment of higher concentrations
of PP1- on the chromosomes to maintain the correct phos-
phorylation/dephosphorylation equilibrium. The combined
data indicate that cells entering mitosis with hyperacety-
lated histones display altered chromatin conformation.
Cells Entering Mitosis in the Presence of TSA Show
Altered Chromosome Condensation and Impaired
Mitotic Progression
The above-mentioned results led us to speculate that chro-
matin condensation into mitotic chromosomes might be af-
fected by the presence of hyperacetylated histones. To avoid
possible artifacts due to fixation procedures, we decided to
investigate mitotic chromosome condensation after deacety-
lase inhibition in living cells. To this aim, we used a stable
Figure 2. Lys 9 H3 acetylation decreases reactivity to the anti-Ser
10 phospho H3 antibody on immunocytochemical preparations. (A)
Immunofluorescence detection of Ser 10 phospho H3 histone in
different mitotic phases in MRC-5 cells treated for 7 h with 500
ng/ml TSA (TSA) or receiving 0.1% DMSO (TSA). First row, an
early prophase cell (arrow) in control culture showing phospho H3
staining. Second row, metaphase (arrow) and anaphase (arrow-
head) cells in control culture showing intense phospho H3 reactiv-
ity. Third and fourth row, metaphase (arrow) and anaphase (arrow)
cells in TSA-treated cultures, in which phospho H3 reactivity is
diminished. Bar, 10 m. (B) Higher magnification of MRC-5 meta-
phase cells immunostained for the phospho-Ser10 H3 histone. A
control metaphase cell (TSA) and a cell treated with 500 ng/ml
TSA for 1 h (TSA) are shown. Bar, 5 m. Note that the antibody
reactivity is confined to the periphery of the chromatid.
Figure 3. Lys 9 H3 acetylation decreases reactivity to the anti-Ser
10 phospho H3 antibody on mitotic cells without affecting MPM-2
staining. (A) Immunofluorescence detection of Ser 10 phospho H3
histone and MPM-2 epitopes on metaphase MRC-5 cells treated
with 0.1% DMSO (TSA) or receiving 500 ng/ml TSA for 7 h
(TSA). The TSA-treated cell shows clear MPM-2 staining and no
phospho H3 reactivity. Bar, 5 m. (B) Analysis of phospo H3 reac-
tivity in MPM-2–positive cells. MRC-5 cells were incubated for 7 h
with 0.1% DMSO (control) or 500 ng/ml TSA (TSA) or received 35
ng/ml nocodazole for 7 h (NOC), or 35 ng/ml nocodazole and 500
ng/ml TSA for 7 h (NOC  TSA). MPM-2–positive metaphases
were classified as weakly positive (example in Figure 2B, TSA) or
negative (example in Figure 3A, TSA) for phospho H3 staining by
eye. About 100 mitoses were scored per experimental point.
Histone Acetylation and Chromosome Segregation
Vol. 14, September 2003 3825
transfectant PtK1 cell line expressing a histone 2B-GFP chi-
meric protein (Cimini et al., 2002). The H2B-GFP protein is
incorporated into nucleosomes, and the resulting bright flu-
orescence of chromosomes makes chromosome structure in
living mitotic cells very easy to observe. H2B-GFP PtK1 cells
were exposed to TSA for 30 min or 5 h and then followed
through mitosis by using fluorescence microscopy (Figure
6). The TSA treatment induced a clear undercondensation of
mitotic chromosomes in all mitotic stages. Already in
prophase, the long thread of condensing chromosomes did
not look homogeneously fluorescent as in control cells (Fig-
ure 6, pro-, TSA), but showed areas of low GFP fluores-
cence alternated with globular fluorescent spots (Figure 6,
pro-, TSA). A decreased compaction of the chromatid
thread was also clear in prometaphase (Figure 6, prometa-,
TSA) and metaphase (Figure 6, meta-, TSA) and was
maintained up to telophase (Figure 6, telo-, TSA). At all
mitotic stages, chromosomes seemed composed of multiple
globular subdomains, suggesting that they did not fold to
the regular level of compaction. To investigate whether this
condensation defect interfered with the regular progression
of mitosis in living cells, we performed phase contrast time-
lapse microscopy to follow mitosis in TSA-treated PtK1 cells.
In our observations, prometaphase length was defined as the
time cells spent between nuclear envelope breakdown and
congression of chromosomes in a tight rod-like metaphase
plate, anaphase onset was marked by sister chromatid sep-
aration, and beginning of telophase by cleavage furrow in-
gression. PtK1 cells were observed under an inverted micro-
scope 30 min or 5 h after TSA addition and mitotic
progression of treated cells was followed thereafter. Time-
lapse analysis of 30 cells per experimental point showed a
statistically significant lengthening of the time cells spent in
prometaphase already for the 30-min TSA treatment (Table
1). After 5 h growth in TSA-containing medium promet-
aphase length was almost doubled and metaphase length
was also statistically increased. This corresponded to a
lengthening of the total time spent in mitosis by TSA-treated
cells (Table 1). Interestingly, a fraction of cells arrested in
prometaphase for 3 h in cultures progressing through
mitosis in TSA-containing medium. For the 5-h TSA treat-
ment, 20% of observed cells did not exit prometaphase dur-
ing the time of observation. These results show that histone
underacetylation in euchromatic and heterochromatic re-
Figure 4. PP1- is recruited on interphase and mitotic chromatin
containing hyperacetylated histones. (A) Immunofluorescence de-
tection of PP1- on interphase MRC-5 cells treated for 1 h with 0.1%
DMSO (TSA) or receiving 500 ng/ml TSA (TSA). PP1- antibody
stains heavily nuclei in TSA-treated cultures. Bar, 10 m. (B) Im-
munofluorescence detection of PP1- on mitotic chromosomes in
MRC-5 cells treated for 1 h with 0.1% DMSO (TSA) or receiving
500 ng/ml TSA (TSA). The metaphase chromosomes from a TSA-
treated culture show an intense PP1- staining. Bar, 5 m.
Figure 5. Lys 9 H3 acetylation does not interfere with Ser 10 H3
phosphorylation. Anti-Ser 10 phospho H3 immunoblotting of nu-
clear proteins in asynchronously growing MRC-5 cells (MRC-5) or
synchronized HeLa cells (HeLa). MRC-5 cells were either incubated
for 7 h with 0.1% DMSO (control) or 500 ng/ml TSA for 1 h (1h TSA)
or 7 h (7 h TSA), or else received 35 ng/ml nocodazole for 7 h (NOC)
or 35 ng/ml nocodazole and 500 ng/ml TSA for 7 h (NOC  TSA).
Nuclear proteins were prepared, immunoblotted with the anti-Ser
10 phospho H3 antibody, and revealed by chemiluminescence.
HeLa cells were synchronized in S phase by a thymidine/aphidi-
colin block. Nuclear proteins were prepared and immunoblotted
with the anti-Ser 10 phospho H3 antibody at the end of the aphidi-
colin treatment (S phase), after 13-h release in complete medium
(mitotic), or after 13-h release in complete medium, including a final
1 h (1 h TSA) or 7 h (7 h TSA) treatment with 500 ng/ml TSA. In both
MRC-5 and HeLa cells, intracellular levels of phospho H3 histone
did not show significant variations after TSA.
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gions is required for proper chromosome condensation and
regular mitotic progression.
Centromeric Heterochromatin Is Modified When
Histone Deacetylation Is Inhibited in Mitosis
Centromeric regions are defined by a compact heterochro-
matic structure that is characterized by chemical modifica-
tions of both DNA and histones. Lys9 methylation on H3
histone has been shown to recruit the heterochromatin-as-
sociated protein HP1, which plays a crucial role in maintain-
ing the compact heterochromatic structure at centromeres
(Eissenberg and Elgin, 2000). Recently, long-term TSA treat-
ments in mouse cells have been reported to disrupt inter-
phase nuclear domains enriched in HP1 proteins (Taddei et
al., 2001). Having observed a defective chromosome conden-
sation after treatment with the deacetylase inhibitor, we
decided to investigate whether a less compact chromatin
structure was present also at the centromere of these under-
condensed chromosomes and whether short-term TSA treat-
ments affected HP1 recruitment to the centromeric regions
of mitotic chromosomes. Human primary fibroblasts and
PtK1 cells were treated for 1 or 7 h with the deacetylase
inhibitor, and cultures were processed for immunofluores-
cence after a mild hypotonic treatment to detect constitutive
kinetochore proteins by CREST staining (Earnshaw and
Rothfield, 1985) and HP1 protein by using an antibody
Figure 6. Chromosome condensation is impaired in living cells when histones are maintained acetylated in mitosis. H2B-GFP–expressing
PtK1 cells were treated for 5 h with 500 ng/ml TSA (TSA) or 0.1% DMSO (TSA) and then observed for H2B-GFP by fluorescence
microscopy. Cells at different mitotic stages are shown: prophase (Pro-), prometaphase (prometa-), metaphase (meta-), and telophase (telo-).
At all mitotic stages, chromosomes in TSA-treated cells were less compact and showed areas of low GFP fluorescence alternated with globular
fluorescent spots. Bar, 5 m.
Table 1. Living cell analysis of the length (mean  s.d.) in minutes of different stages of mitosis in PtK1 cells progressing through mitosis
in TSA-containing medium
N Prometaphase Metaphase Anaphase Telophase/Cytokinesis Total
5 h DMSO 29 18.8  9.4 21.6  11.6 17.1  6.2 17.8  9.6 75.3  25.1
30 min TSA 30 26.9  17.9a 24.4  21.5 15.1  7.6 22.0  16.3 87.5  38.6c
5 h TSA 29 40.4  15.9b 27.8  10.8a 18.7  8.4 24.4  16.0 108.9  20.9bd
Cells were exposed to TSA for the indicated times before observation and kept in TSA-containing medium during the experiment. N  total
number of cells analyzed.
a Student t test, p  0.05; b, Student t test, p  0.01, when values were compared to DMSO treatment.
c 1 cell: prometaphase arrest ( 3 h); 1 cell: metaphase arrest ( 3 h); 3 cells: absence of cytokinesis.
d 6 cells: prometaphase arrest ( 3 h); 2 cells: absence of cytokinesis.
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directed against the HP1 isoform. HP1 protein was asso-
ciated to chromatin during mitosis and preferentially con-
centrated at the centromeric regions of mitotic chromosomes
in untreated cells (Figure 7, TSA, Remboutsika et al., 1999).
Combined immunodetection of kinetochore (CREST) and
HP1 proteins showed that the region of HP1 accumulation at
centromeres was much larger than the CREST signal and
overlapped the inner centromeric area between the two
CREST-stained sister kinetochores (Figure 7, TSA, right
column). In TSA-treated cells, the HP1-chromatin associa-
tion was maintained but the preferential accumulation at the
centromeric heterochromatin was diminished (Figure 7,
TSA). Mean HP1 fluorescence intensity on kinetochore
regions was quantified in at least 51 kinetochores per exper-
imental point and results for PtK1 and MRC-5 cells are
shown in Figure 7B. Statistically significant reductions in the
mean HP1 fluorescence intensities at kinetochores were ob-
served both in MRC-5 and PtK1 cells treated for 1 or 7 h with
Figure 7. Heterochromatin protein 1 accumulation at centromeres is impaired in cells briefly exposed to TSA. (A) Immunofluorescence
detection of HP1 and kinetochore proteins by using 2HP 1H5 antibody and CREST serum on PtK1 metaphase cells from cultures treated
for 7 h with 0.1% DMSO (TSA) or 500 ng/ml TSA (TSA). DNA was counterstained using DAPI (blue). The right column shows an overlay
of CREST, HP1, and DAPI staining. HP1 is detected at centromeres in a region wider than the one defined by the CREST antibody in the
control cell (top, middle panel). In the TSA-treated cell the centromeric accumulation is lost (bottom, middle panel). Bar, 5 m. (B)
Quantitative analysis of HP1 fluorescence on MRC-5 and PtK1 cells treated for 7 h with 0.1% DMSO (red bars) or receiving 500 ng/ml TSA
for 1 h (white bars) or 7 h (gray bars). The values shown are the mean  SE of kinetochore fluorescence intensities (obtained as described
in MATERIALS AND METHODS). Numbers above bars represent numbers of kinetochores measured per each experimental condition. p 
0.001 when TSA-treated samples were compared with their respective controls by the Student’s t test.
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TSA. Differences ranged between 25% (PtK1, 7 h) and 50%
(MRC-5, 1 h) reduction compared with their respective con-
trols (p  0.001 for all comparisons).
Inhibition of Histone Deacetylation Produces
Chromosome Segregation Defects in Anaphase Cells
To assess whether the persistence of acetylated histones on
mitotic chromosomes interfered with chromosome segrega-
tion in mitosis we performed an analysis of chromosome
segregation defects in human primary fibroblasts. The anal-
ysis of 1000 anaphase MRC-5 cells by DAPI and CREST
staining showed that the TSA treatment significantly in-
duced lagging chromosomes (2 test, p  0.01), i.e., chromo-
somes left behind at the spindle equator during anaphase
(Figure 8A, left column, and B). Both lagging of single chro-
matids showing one CREST signal and lagging of paired
sisters with two CREST signals were observed (Figure 8B).
We could identify such lagging as paired sisters, because the
Figure 8. Chromosome segregation defects in TSA-treated MRC-5 cells derive from defective sister chromatid separation. (A) Immuno-
fluorescence detection of kinetochores and DNA staining on anaphase cells, showing lagging chromosomes or chromatin bridges. The
lagging chromosome shows two paired CREST signals (arrow). The chromatin bridge shows two extended CREST signals at the ends of the
bridge (arrows). Bar, 5 m. (B) Quantitative analysis of the induction of chromosome segregation defects after TSA treatment. Lagging
chromosomes were classified as showing one CREST signal (single sisters) or two paired CREST signals (paired sisters) both in DMSO- and
TSA-treated cells. Chromatin bridges, both in TSA-treated cells and DMSO-treated cells, were classified as follows: without identifiable
CREST signal (without CREST signal); with CREST signal at opposite ends of the bridge (CREST distal); with CREST signal along the
chromatin bridge (CREST central). The graph shows results obtained scoring 937 anaphase cells in DMSO-treated cells and 921 anaphase cells
in TSA-treated cultures. Data from 1-h and 7-h treatments with TSA were pooled because no appreciable differences were observed. (C)
Fluorescence in situ hybridization with chromosome 16-specific alphoid probe (fluorescein isothiocyanate, green) and chromosome 1 classical
satellite probe (rhodamine, red) on anaphase MRC-5 cells after treatment with TSA. DNA was counterstained with DAPI (blue). A regular
distribution of the two chromosomes is expected to give two green signals and two red signals on each group of segregated chromosomes
(normal cell). Some chromatin bridges on anaphase cells showed two extended red (chromatin 1 bridge) or green (chromosome 16 bridge)
signals at the opposite ends of the connecting chromatin. In other cases, the centromeric signal totally overlapped the chromatin bridge
(centromeric bridge). Anaphases (519) were scored in TSA-treated cells and 11 chromatin bridges involving either chromosome 1 or
chromosome 16 were recorded. Two of 11 were centromeric bridges.
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size of the two paired chromatids was the same and the two
CREST signals were close to each other (an example is
shown in Figure 8A). However, the predominant segrega-
tion defect was constituted by bridges of chromatin between
the two reforming daughter nuclei (Figure 8B; p  0.001, 2
test). Chromatin bridges in control cells always looked like
DAPI-stained material stretched between the two groups of
migrated chromosomes (Figure 8B, no CREST signal). Con-
versely, a substantial fraction of chromatin bridges in TSA-
treated cells showed kinetochore signals at both ends of the
DAPI-stained connecting material (example in Figure 8A; B,
CREST distal). Alternatively, stretched kinetochore signals
could be observed along the DNA extending in between the
two groups of segregating chromosomes (Figure 8B, CREST
central), suggesting that the DNA bridge between the two
connected centromeres was much shorter than in control
cells or that the two centromeres could not split. Similar
results were obtained in cells that received the drug either
for 1 or 7 h, suggesting that the critical time window for TSA
action was just at the beginning of mitosis, when chromo-
some condensation is achieved.
To analyze more in detail such chromatin bridges, we
applied fluorescence in situ hybridization with centromeric
probes on anaphase cells. Chromosome 1 classical satellite
and chromosome 16 alphoid DNA sequences were labeled
with different fluorochromes to detect the segregation of
these chromosomes at anaphase. As shown in Figure 8C
(normal cell) the regular distribution of chromosomes at
anaphase would elicit 2 signals for each chromosome in each
group of segregated chromosomes. Chromatin bridges in
TSA-treated cultures often displayed two centromeric sig-
nals for one of the chromosomes under study at opposite
ends of the bridge, whereas the two other centromeric sig-
nals were correctly localized at the two poles (Figure 8C,
Chrom 1 bridge, Chrom 16 bridge), indicating that chroma-
tin bridges were sister chromatids that remained connected
during anaphase. In other cases, chromatin bridges in TSA-
treated cells extended over the centromeric signals and the
centromeres were highly stretched (Figure 8C, centromeric
bridge). Together, these results show that sister chromatids
could not separate when cells entered mitosis with hyper-
acetylated histones. Thus, the presence of acetylated his-
tones in mitosis induced both aberrant chromosome num-
bers (i.e., aneuploidy) and defects in chromosome structure.
DISCUSSION
Condensation of DNA into chromosomes, resolution of the
two sister chromatids and physical separation of the two
sisters are the mitotic chromatin events essential for proper
chromosome segregation during cell division. These events
require dramatic changes in chromatin structure that are
achieved through histone tail modifications by chromatin-
modifying enzymatic complexes and by the action of several
other enzymatic activities such as condensins and cohesins,
topoisomerase II, and the securin/separin pathway (re-
viewed in Hans and Dimitrov, 2001; Losada and Hirano,
2001; Nasmyth, 2002). Our results discover new aspects of
the interplay between histone modifications, sister chroma-
tid condensation and cohesion, and chromosome segrega-
tion, and they provide new mechanistic insights into the
origin of genome instability in mammalian cells.
Chromosome Structure Is Profoundly Altered When
Histones Are Maintained Acetylatetd in Mitosis
In cells undergoing mitosis with hyperacetylated chromatin,
the presence of H3 Lys 9 acetylation did not inhibit H3 Ser
10 phosphorylation. This result is consistent with the coex-
istence of Ser 10 phosphorylation and Lys 9 acetylation on
histone H3 upon gene activation (Clayton et al., 2000), the
increased kinase activity of recombinant Ipl1/aurora kinase
on acetylated H3 substrates (Rea et al., 2000), and our own
data on phospho H3 levels in nuclear proteins after treat-
ment with the deacetylase inhibitor (Figure 5). However,
phospho H3 antibody reactivity of TSA-treated mitotic chro-
mosomes was greatly reduced in immunofluorescence stud-
ies (Figure 2), indicating that the presence of acetylated
histones in mitotic chromosomes decreases the accessibility
of histone N-tails to the antibody for Ser 10 phospho H3. The
results presented suggest that the decreased antibody reac-
tivity depends on a modified association of hyperacetylated
histone tails to DNA and a consequent distortion in chro-
matin structure. A reduction in H3 N-tail/DNA binding is
associated with mitotic H3 phosphorylation and chromo-
some condensation and may be involved in promoting the
binding of condensation factors such as topoisomerase II
and the condensin complex to the modified chromatin
(Sauve’ et al., 1999). Our data support the idea that this
chromatin remodeling process is strongly altered when hi-
stones are hyperacetylated during mitotic condensation,
producing mitotic chromosomes with altered three-dimen-
sional structure. This conclusion is corroborated by the
stronger association of the human chromatin-associated
phosphatase PP1- to acetylated mitotic chromosomes (Fig-
ure 4). Indeed, a modified chromatin conformation may
stimulate phosphatase loading on H3 phosphorylated chro-
matin to maintain an adequate balance of kinase and phos-
phatase activities during mitosis (Murnion et al., 2001, Sug-
iyama et al., 2002).
Consequent to the modifications in chromatin conforma-
tion identified by antibody staining and protein association,
we showed that inhibition of histone deacetylation shortly
before mitosis produces defects in chromosome condensa-
tion in living cells (Figure 6). This indicates that association
of condensation factors on chromatin is dependent on a
favorable chromatin structure, which requires both Lys 9
deacetylation and Ser 10 phosphorylation. In line with this
idea is the observation that Aurora B-depleted Drosophila
cultured cells show altered chromosome condensation and
defective association of the condensin Barren protein to-
gether with reduced H3 phosphorylation (Giet and Glover,
2001). The impaired association of HP1 protein to the cen-
tromeric region observed in Ptk1 and human cells after TSA
treatment (Figure 7) demonstrates that centromeric chroma-
tin structure is also altered when histones are maintained
acetylated in mitosis. This may be explained by the fact that
acetylation of Lys 9 residues prevents methylation by the
SUV39H1 methyltransferase (Rea et al., 2000, Nakayama et
al., 2001). Given the strong specificity of the HP1/Swi6 chro-
modomain for Lys 9 methylated H3 (Bannister et al., 2001;
Jacobs et al., 2001; Nakayama et al., 2001), HP1 association to
heterochromatin containing Lys 9 acetylated H3 may be
defective. Our data show that acetylation-dependent defec-
tive accumulation of HP1 onto heterochromatin occurs not
only after several day exposure to TSA, as shown by Taddei
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et al. (2001), but also when histones are maintained hyperacety-
lated specifically during prophase. These results highlight the
dynamism of histone modifications and chromatin structure
during mitosis, suggesting that Lys 9 H3 histone methylation
still occurs during chromosome condensation. This is consis-
tent with the high level of H3 methyltransferase activity ob-
served in HeLa mitotic cells (Rice et al., 2002).
In our live cell observation of mitotic progression, a signifi-
cant lengthening of prometaphase and metaphase was ob-
served. Furthermore, 20% of observed cells were blocked in
prometaphase in the presence of TSA (Table 1). This raises the
possibility that an improper chromosome condensation can
affect kinetochore–microtubule interaction, inducing mitotic
checkpoint activation and cell cycle arrest in prometaphase.
Furthermore, the metaphase lengthening observed in TSA-
treated cells, indicates that even when all chromosomes cor-
rectly align at the metaphase plate, a mitotic delay is induced in
response to the defect in chromosome condensation. This sug-
gests the intriguing possibility that the mitotic checkpoint can
detect not only kinetochore-microtubule attachment but also
chromosome three-dimensional architecture during mitosis.
Conformational defects in the centromeric region, due to his-
tone hyperacetylation-dependent HP1 dispersal might be the
architectural defects monitored by the mitotic checkpoint after
deacetylase inhibitors.
Chromosomal passenger proteins might be good candi-
dates as molecular players that connect the chromosome
condensation process with mitotic progression. These pro-
teins localize along the whole chromosome length during
prophase and move to the inner kinetochore domain during
prometaphase. It can be speculated that inhibition of chro-
mosome condensation by histone hyperacetylation may in-
terfere with the dissociation of these proteins from chromo-
some arms, inhibiting their accumulation and function at
kinetochores. The passenger protein Aurora B kinase has
been shown to be responsible for the tension-dependent
activation of the mitotic checkpoint and has been suggested
to promote sister kinetochore biorientation (reviewed in
Shannon and Salmon, 2002, Tanaka, 2002). This protein may
be an excellent candidate as mediator of the mitotic delay
induced by histone hyperacetylation, thus integrating the
chromosome condensation process with kinetochore-
microtubule attachment and mitotic progression.
Histone Hyperacetylation Prevents Sister Chromatid
Resolution and Centromere Separation
Cells reaching anaphase in the presence of the deacetylase
inhibitor TSA showed increased frequencies of chromosome
segregation defects, such as lagging chromosomes and chro-
matin bridges (Figure 8). These mitotic abnormalities were
present also for exposure times that affected histone deacety-
lation only during late G2/prophase, suggesting a critical
time window when histone deacetylation is required for
proper chromosome condensation and segregation.
Both chromatin bridges derived from persistent cohesion
along sister chromatid arms and chromatin bridges due to
persistent cohesion at the centromere were observed in our
FISH studies. However, the majority of chromosomes pro-
ducing chromatin bridges showed persistent cohesion along
sister chromatid arms but proper centromere separation,
demonstrating that inhibition of histone deacetylation in
mitosis affects chromosome cohesion along chromatid arms
more than at the centromere. It is now becoming clear that
chromatin dynamics in mitosis is regulated by the coordi-
nated action of cohesin and condensin activities and that
condensin loading on DNA promotes cohesin dissociation
(Losada and Hirano, 2001; Nasmyth, 2002). It has been pro-
posed that chromosome arm cohesion in mammalian cells is
removed in prophase through a separin-independent mech-
anism and that centromeric cohesion is released by Scc1
cleavage at the metaphase to anaphase transition
(Waizenegger et al., 2000). Our data provide cytological ev-
idence that the release of centromeric cohesion is indepen-
dent from sister chromatid resolution and that this last pro-
cess is strongly influenced by histone hyperacetylation. It
can be speculated that impaired association of condensation
factors on hyperacetylated chromatin may alter the dissoci-
ation of cohesins during early mitotic stages, resulting in
persistent cohesion along chromatid arms. The separin-de-
pendent release of centromeric cohesins at anaphase onset
would promote the formation of chromatin bridges between
sister chromatids due to poor sister chromatid arm resolu-
tion, as already reported for condensin mutants (Bhat et al.,
1996; Ouspenski et al., 2000, Steffensen et al., 2001) or after
inhibition of sister chromatid decatenation by topoisomerase
II inhibitors (Cimini et al., 1997). On the other hand, a lack of
sister chromatid separation at the centromere level is clearly
indicated by the observation of chromatin bridges spanning
the centromeric region. It can be hypothesized that the dis-
entangling of centromeric DNA by topoisomerase II may be
defective when the centromeric structure is distort due to
histone hyperacetylation. In line with this, induction of
polyploidy through a lack of centromere separation has been
found in Suv39h histone methyltransferase-deficient mice
(Peters et al., 2001).
Among TSA-induced lagging chromosomes, either single
chromatid or paired sister chromatids with two CREST sig-
nals were observed. Previous studies in PtK1 and human
cells have demonstrated that lagging chromosomes at an-
aphase are single sisters that cannot migrate because their
kinetochore is attached to microtubules coming from oppo-
site spindle poles (merotelic kinetochore orientation)
(Cimini et al., 2001, 2002). Our results suggest that when HP1
is not correctly assembled on the centromeric heterochroma-
tin in human cells, the less constrained centromeric organi-
zation may promote the attachment of individual kineto-
chores to microtubules coming from both spindle poles, thus
producing anaphase-lagging chromosomes. A similar mech-
anism for the origin of lagging chromosomes has been pro-
posed from work in yeast cells (Bernard et al., 2001; Bernard
and Allshire, 2002). Disruption of centromeric architecture
by loss of heterochromatin components may also promote
the assembly of sister kinetochores that have distort recip-
rocal orientations, which would allow both of them to be-
come merotelically oriented. When merotelic kinetochore
orientation and persistent sister chromatid cohesion at the
centromere level occur at the same time, the possibility that
sister chromatids separate at anaphase will be further re-
duced. This would explain the observation of lagging chro-
mosomes representing both sisters with closely paired
CREST signals. It can be hypothesized that the final disen-
tangling of the two sister chromatids at anaphase onset
requires both loss of cohesion mediated by SCC1 degrada-
tion and tension at kinetochores induced by opposite trac-
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tion forces. When both sister kinetochores are merotelically
oriented, the tension in opposite directions at the centromere
may be strongly reduced, inhibiting centromere separation.
In conclusion, our results highlight the fact that both
persistence of cohesion along chromatid arms and at centro-
meres are responsible for defects in chromosome segrega-
tion and chromosome structure when histones are main-
tained acetylated during mitosis. Furthermore, defective
kinetochore–microtubule interactions leading to lagging
chromosomes seem to be favored when centromeric hetero-
chromatin possess a less constrained structure due to HP1
depletion.
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